Healthcare provider profile · identity verified

Nadine Abrahim, MD

Family Practice · LEAGUE CITY, TX · NPI 1366001372

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	229	77
Levothyroxine Sodium	Levothyroxine Sodium	206	53
Amlodipine Besylate	Amlodipine Besylate	169	59
Losartan Potassium	Losartan Potassium	147	50
Rosuvastatin Calcium	Rosuvastatin Calcium	136	43
Meloxicam	Meloxicam	126	44
Hydrochlorothiazide	Hydrochlorothiazide	106	38
Lisinopril	Lisinopril	103	37
Metformin Hcl	Metformin Hcl	99	28
Pantoprazole Sodium	Pantoprazole Sodium	96	33
Gabapentin	Gabapentin	84	30
Metoprolol Succinate	Metoprolol Succinate	79	22
Tizanidine Hcl	Tizanidine Hcl	79	36
Trazodone Hcl	Trazodone Hcl	63	18
Doxepin Hcl	Doxepin Hcl	57	12
Carvedilol	Carvedilol	56	17
Buspirone Hcl	Buspirone Hcl	55	14
Escitalopram Oxalate	Escitalopram Oxalate	55	18
Tamsulosin Hcl	Tamsulosin Hcl	55	18
Metformin Hcl Er	Metformin Hcl	54	21
Furosemide	Furosemide	51	18
Omeprazole	Omeprazole	48	17
Fluticasone Propionate	Fluticasone Propionate	47	19
Albuterol Sulfate Hfa	Albuterol Sulfate	46	20
Ozempic	Semaglutide	46	suppressed
Sertraline Hcl	Sertraline Hcl	46	14
Mounjaro	Tirzepatide	41	suppressed
Jardiance	Empagliflozin	40	12
Zolpidem Tartrate	Zolpidem Tartrate	37	suppressed
Alendronate Sodium	Alendronate Sodium	36	12
Duloxetine Hcl	Duloxetine Hcl	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Atenolol	Atenolol	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Tramadol Hcl	Tramadol Hcl	28	suppressed
Valacyclovir	Valacyclovir Hcl	27	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Bupropion Xl	Bupropion Hcl	22	11
Olmesartan Medoxomil	Olmesartan Medoxomil	22	suppressed
Simvastatin	Simvastatin	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Glimepiride	Glimepiride	19	suppressed
Potassium Chloride	Potassium Chloride	19	suppressed
Januvia	Sitagliptin Phosphate	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Montelukast Sodium	Montelukast Sodium	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Finasteride	Finasteride	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Amoxicillin	Amoxicillin	15	14
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Allopurinol	Allopurinol	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Famotidine	Famotidine	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Eliquis	Apixaban	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Pregabalin	Pregabalin	12	suppressed
Promethazine Hcl	Promethazine Hcl	12	suppressed
Valsartan	Valsartan	12	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Ropinirole Hcl	Ropinirole Hcl	11	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	11	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error